Back
Xylem Vs. Keros Therapeutics Industry Stock Comparison
Buy
68
XYL
Xylem
Last Price:
142.98
Seasonality Move:
3.5%
Sell
22
KROS
Keros Therapeutics
Last Price:
54.31
Seasonality Move:
-7.87%
Buy
68
Xylem (XYL)
is a Buy
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $142.61. The Score for XYL is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- XYL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.77. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.39 | Buy |
| Relative Strength Index (14 RSI): | 80.92 | Buy |
| Chaikin Money Flow: | 831671 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (126.87 - 136.37) | Buy |
| Bollinger Bands (100): | (114.68 - 131.28) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 45.82 | Sell |
| Chaikin Money Flow: | -118658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.33 - 61.13) | Sell |
| Bollinger Bands (100): | (48.12 - 66.12) | Buy |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.24 | Buy |
| 20-day SMA: | 132.42 | Buy |
| 50-day SMA: | 129.77 | Buy |
| 200-day SMA: | 110.87 | Buy |
| 8-day EMA: | 138.17 | Buy |
| 20-day EMA: | 134.17 | Buy |
| 50-day EMA: | 129.54 | Buy |
| 200-day EMA: | 116.27 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.33 | Sell |
| 20-day SMA: | 57.78 | Sell |
| 50-day SMA: | 62.6 | Sell |
| 200-day SMA: | 45.07 | Buy |
| 8-day EMA: | 58.31 | Sell |
| 20-day EMA: | 58.8 | Sell |
| 50-day EMA: | 59.44 | Sell |
| 200-day EMA: | 50.57 | Buy |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.07 per share, an increase this year of $0.48 per share, and an increase next year of $0.51 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Xylem Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||